Pancreatic Cancer Research

ResearcherQingdao UniversityActive in the last 2 years

Ruoxi Xiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0801-7005; OpenAlex author ID A5070279174. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2026: 2 papers

Papers 2

  1. EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer. Co-author DOI 10.1002/mco2.70860↗
  2. Siglec Ligand Profiling on Extracellular Vesicles Reveals a Cancer-Related Signature with Immunosuppressive Function in Pancreatic Cancer. First author DOI 10.1002/smll.75407↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhu Guo · 1 shared paper, 2026 · strength 0.33
  2. Ping Li · 1 shared paper, 2026 · strength 0.33
  3. Ke Lei · 1 shared paper, 2026 · strength 0.28
  4. Ruining Gong · 1 shared paper, 2026 · strength 0.28
  5. Junjin Wang · 1 shared paper, 2026 · strength 0.28
  6. He Ren · 1 shared paper, 2026 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.